Background Patient survival after severe burn injury is largely determined by burn size. Modern developments in burn care have greatly improved survival and outcomes. However, no large analysis of outcomes in paediatric burn patients with present treatment regimens exists. This study was designed to identify the burn size associated with signifi cant increases in morbidity and mortality in paediatric patients.
Introduction
Prediction of survival and outcomes has always been an important goal in the treatment of thermally injured patients. In the 1980s and early 1990s, clinical predictions and decisions were based mainly on burn size. [1] [2] [3] In 1998, Ryan and colleagues 4 assessed improvements in burn care in a large population of 1665 patients treated between 1990 and 1996, and developed a prediction model for individual patient risk and identifi ed burn size of 40% of total body surface area (TBSA) as a risk factor for poor outcome. This model was based on injury characteristics, initial treatment, and biochemical markers during admission and hospital stay. 4 However, during the past 10 years, additional improvements in care have further reduced morbidity and improved survival rates and outcomes after extensive burn injuries. Novel drug treatments, new grafting techniques and materials, and lifesupport systems combined with improved sensitivity of monitoring methods have all led to improved care after severe thermal injury. 5 In this study, we analysed postburn prognosis in paediatric patients. Especially in children, the probability of survival and the incidence of complications are important to know as a reference for the decision to transfer to a specialised burn centre, as well as for treatment decisions at admission and during hospital course. This study focused on children, with the advantage that in children and adolescents, the hospital course is mainly determined by the eff ect of the burn injury and not by pre-existing comorbidities. Additionally, in this patient population the estimated life expectancy is not taken into account and decisions are based on survival probability. This study had three aims: (1) to establish the burn size, as expressed by TBSA, associated with increased morbidity and mortality; (2) to assess outcomes in relation to burn size; and (3) to correlate patient outcomes with biochemical markers and measures of organ dysfunction. This investigation was intended to provide a rationale for clinical decisions based on survival, expected complication rates, and outcome after burn injury.
Methods

Patients and procedures
The study was approved by the institutional review board of the University of Texas Medical Branch (Galveston, TX, USA). Informed consent was obtained from each patient, parent, or child's legal guardian. All acutely burned patients arriving at our burn centre were included in this analysis to be consistent with a previously published trial and to compare the outcomes from the previous study to our study. 4 Thermally injured children admitted to the burn unit with burns of 30% of their TBSA or greater were enrolled. Patients were resuscitated according to the Galveston formula with 5000 mL/m² TBSA burned plus 2000 mL/m² TBSA lactated Ringer's solution, given in increments during the fi rst 24 h as necessary. Within 48 h of admission, all patients underwent total burn wound excision, and their wounds were covered with autograft. Any remaining open wound areas were covered with homograft. Admission and treatment criteria were based on the guidelines published by the American Burn Association. 6 All patients received similar nutritional treatment according to a standardised protocol. Intake was calculated as 1500 kcal/m² body surface plus 1500 kcal/m² area burned. 7 Patient demographic and injury characteristics, hospital course, morbidity, and mortality were recorded. Sepsis was defi ned according to the modifi ed American College of Chest Physicians/ Society of Critical Care Medicine criteria. 8, 9 Multiorgan failure was assessed according to DENVER2 score. 9 We further established the time between operations, judging this measure to be refl ective of donor site healing and, therefore, an estimate of wound healing and reepithelisation. Patient data were obtained prospectively and were processed and analysed with Microsoft Access and Excel (2010 versions).
As part of our routine clinical practice, all patients underwent resting energy expenditure measurements within 1 week of hospital admission and every week thereafter during their acute hospital stay. Resting energy expenditure was measured with a Sensor-Medics Vmax 29 metabolic cart (Yorba Linda, CA, USA) and calculated as described by Mlcak and colleagues 7 (n=696). Liver ultrasound measurements (n=405) were made with the HP Sonos 100 CF echocardiogram (Hewlett Packard Imaging Systems, Andover, MA, USA). The liver was scanned with an Eskoline B-scanner, and liver size/ volume was calculated with a formula as previously described. 10 Actual size was then compared with predicted size for healthy volunteers.
Blood and urine samples were obtained from every patient at admission and during the acute stay until discharge and were used for serum hormone (n=479), protein (n=713), and cytokine (n=461) analysis. Serum hormones and acute phase proteins were measured with high-performance liquid chromatography, nephelometry (BNII, Plasma Protein Analyzer, Dade/Behring/ Siemens, Tarrytown, NY, USA), and ELISA techniques. Burn to admission (days)
Data are n (%), mean (SD), or p value. TBSA=total body surface area. 
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Results
952 thermally injured children admitted to the burn unit with burns of 30% of their TBSA or greater were enrolled between Jan 1, 1998, and Sept 6, 2008. Burn size ranged from 30% to 100% TBSA, and most patients had burns between 40% and 50% TBSA. On the basis of burn size, we stratifi ed patients into seven groups using 10% increments between 30% and 100% TBSA. Sex distribution, ethnic origin, and time from burn to admission were similar in all groups ( (table 2) . Large burns also needed a greater number of operations during acute hospital stay than did smaller burns, starting with a mean of 2·1 operations for patients with burns of 30-39% TBSA, and increasing to 8·6 operations for 90% TBSA burns (p<0·0001). The time needed between surgeries also increased accordingly (p<0·0001). Multiorgan failure, including the maximum DENVER2 and sepsis scores, was also correlated with increasing burn size, showing a signifi cantly higher incidence for burns greater than 60% TBSA than for smaller burns (p<0·0001). The same eff ect occurred in the number of minor infections (<60% TBSA, 2·8-4·1, vs ≥60% TBSA, 7·7-10·4 per 10% group) during the ICU stay (p<0·0001). Mortality increased signifi cantly (p<0·0001) relative to burn size (fi gure 1). A large increase in mortality was evident starting at 60% TBSA, with the Kaplan-Meier survival curve showing a signifi cant diff erence in shortterm and long-term survival (p=0·00131) between the groups with burns smaller than or larger than 60% TBSA. However, in patient groups with burns smaller than 60% TBSA, there were only minor increases in mortality starting at 3% and reaching up to 7%. To validate these fi ndings, we undertook ROC analysis for mortality to establish the critical value for survival, with the threshold identifi ed as 62% TBSA. The ROC curve validated this fi nding, with a fair value of A=0·81 for prediction of survival (fi gure 1).
Using multiple logistic regression, after adjustment for inhalation injury, sex, age, and burn-to-admission time, we showed that TBSA greater than 60% was a 
Time between operations (days)
Length of stay in ICU (days)
Length of stay/TBSA, third-degree 
Data are mean (SD), n (%), or p value. TBSA=total body surface area. strong predictor of mortality with an odds ratio of death that was ten times higher (p<0·0001) than that for patients below this threshold, confi rming that burn size was the main factor for the estimate of survival. Inhalation injury was associated with an odds of death that was nearly three times higher (p<0·0001) than that for patients without this injury. Age and time from burn to admission were not associated with mortality diff erences in this patient population during the hospital stay (table 3) .
Inhalation injury contributes to mortality, and in each burn group examined, patients with inhalation injury had a signifi cantly higher mortality than did patients without this injury (webappendix pp 1-2). An ROC cutoff analysis for burn size with inhalation injury was not done because most patients with inhalation injury had a signifi cantly larger burn size, skewing the data to a higher threshold than a lower, which would be an observational error.
Blood glucose (p<0·0001) and insulin concentrations (p=0·036) were signifi cantly increased in the group with large burns during the whole study period, with a slight normalisation by day 60 (fi gure 2). Analysis of resting energy expenditure showed signifi cantly higher values at discharge than at admission in each group. These values signifi cantly (p=0·043) increased with burn size (fi gure 2), refl ecting caloric needs after burn injury. Liver size normalised for age, expressed as percentage of predicted value, increased from admission to discharge from hospital with increasing burn size (p=0·05). Although only a slight increase in liver size was noted in patients with burns up to 59% TBSA, a massive and signifi cant increase occurred between admission and discharge for patients with larger burns (fi gure 2). Age at admission (years) 1·022 (0·98-1·07) 0·3489
Burn to admission (days) 0·99 (0·92-1·06) 0·6651
TBSA=total body surface area. Production of liver constitutive proteins is shown in fi gures 2 and 3. Both burn size groups showed a decrease in all measured proteins, which began to normalise after the fi rst week postinjury. Total protein, apolipoprotein B, apolipoprotein A1, prealbumin, and transferrin were all signifi cantly (all p<0·05) decreased in the larger burn group (fi gure 2). A change in retinol binding protein after day 10 postburn was noted, with the expression of this protein being signifi cantly less in the smaller burn group (p=0·019). Triglycerides were also signifi cantly higher in the larger burn group at several timepoints (p=0·045).
All measured cytokines (fi gure 3) showed major diff erences between the two burn size groups during the monitored time period from immediately postburn up to 60 days after the injury (p<0·05). In the larger burn group, interleukin 8 (p=0·037) and interleukin 10 (p=0·039) remained signifi cantly increased over most of the study period. Macrophage infl ammatory protein 1β (days 2-28; p=0·035) and interleukin 13 (days 2-22; p=0·020) also remained signifi cantly increased. Figure 3 shows the cytokine response grouped for important cellular response mechanisms, as well as macrophage activity, cell death, and repair mechanisms. Levels of tumour necrosis factor α (TNFα) and granulo cyte colonystimulating factor (G-CSF) were signifi cantly and constantly increased from day 2 to day 60 (p=0·032 and p=0·036, respectively). Interferon γ and granulocytemacrophage colony-stimulating factor (GM-CSF) were signifi cantly higher in patients with burns greater than 60% TBSA between days 2 and 22 (p=0·038 and p=0·010, respectively). Established markers of the infl ammatory response are shown in fi gure 3, where we selected interleukin 6 and C-reactive protein. These showed an immediate rise after burn, with signifi cant diff erences throughout the whole study period (p=0·036 and p=0·0002, respectively). The liver-synthesised C-reactive protein increased more slowly after day 1 postburn and then increased rapidly from day 8. Liver and renal function were monitored by aspartate transaminase, total bilirubin, blood urea nitrogen, and serum creatinine (fi gure 3). Blood urea nitrogen remained increased during the fi rst 60 days (p=0·00066), with signifi cantly higher values being recorded during the observational period in the larger burns group than in patients with smaller burns. Serum creatinine was signifi cantly increased up to day 28 (p=0·015) and then remained similar in both groups. Representative of liver impairment, total bilirubin was signifi cantly (p=0·013) increased in the larger burns group during the whole study period, and aspartate transaminase remained increased for the fi rst 34 days (p=0·042).
Discussion
Building on previous studies, 4, 11 this study identifi ed the critical burn size determining major complications and survival with state-of-the-art, modern burn care. In this study we accumulated a large patient population, which we used to assess the crucial threshold for survival and to corroborate with biochemical markers. We noted that mortality was nearly equal in patients with burns up to 60% TBSA, but for those with larger burns, the mortality rate increased substantially. Impor tant to note are the relatively low mortality rates in even the most extensively burned patients (55% for ≥90% TBSA), which in our opinion were attributable to an improved and aggressive treatment regimen.
As a cofactor contributing to mortality besides the extent of the burn, inhalation injury was examined. The presence or absence of inhalation injury aff ects outcomes, and our data suggest that inhalation injury worsens postburn morbidity and mortality. We did not do an ROC cutoff analysis for patients with burns and presence of inhalation injury because of the uneven distribution of these patients. Patients with inhalation injury had larger burns than did patients without inhalation injury, which would skew the data towards larger burns. We recommend that the treating physician keeps in mind that the presence of inhalation injury signifi cantly aff ects postburn outcomes. Of interest, patient's age and the time from injury to admission to a specialised burn centre did not signifi cantly contribute to in-hospital mortality.
We noted that mortality peaked within the fi rst 20 days after admission and showed a prolonged increase related to burn size. In accordance with these fi ndings, the incidence of sepsis and multiorgan failure combined with maximum DENVER2 score and infections correl ated with burn size. For burns up to 49% TBSA, the incidence of these complications remained at 6-12% for multiorgan failure and 2-6% for sepsis, but increased up to 27-45% for multiorgan failure and 15-26% for sepsis in the group with burns greater than 60% TBSA. As expected, the number of necessary surgeries during the acute stay increased with the size of burn. These results are refl ected by important organ-specifi c clinical measures as well as metabolic and infl ammatory responses. 12, 13 Insulin resistance, a hallmark postburn, was confi rmed in this study. [14] [15] [16] We showed that insulin resistance worsened with increased burn size, with higher blood glucose concentrations being present in the extensively burned group despite higher serum insulin concen trations. Changes in glucose metabolism were associated with changes in lipid metabolism. Serum triglyceride concentrations rose signifi cantly, and these increases persisted signifi cantly longer with a larger burn size. These metabolic changes were also refl ected in metabolic rate determined by resting energy expenditure. Patients with larger burns had profoundly higher metabolic rates and demands for a prolonged period of time than did those with smaller burns. Metabolic demands are refl ected in organ function. The larger the burn, the worse the liver structure and function, with profoundly depleted con stitutive proteins and dramatic hepato megaly, which is most likely due to oedema formation early after burn and hepatic lipid infi ltration later in hospital course. 12, 13 Our data also showed a profound eff ect on kidney and pulmonary function most likely due to the massive protein catabolism and wasting postburn. The aforementioned data all suggest that severely burned patients undergo a massive hypermetabolic response aff ecting all organs and contributing to postburn morbidity and mortality.
The hypermetabolic state can be at least partly attributed to the infl ammatory response. Infl ammatory mediators G-CSF, interleukin 8, and interleukin 10 showed an immediate increase with a decrease over time in both populations; however, the greater than 60% TBSA burn group had signifi cantly higher levels of these factors than did the smaller burn group. Interleukin 8 targets a fairly wide range of cells including primary neutrophil granulocytes, mast cells, macrophages, endothelial cells, and keratino cytes. Several studies have shown that interleukin 8 causes localised infl ammation leading to oxidative stress. 15, 17 This eff ect would correlate with the tremendous diff erence between groups during the whole study period, refl ecting post-traumatic tissue infl ammation, which is seen clinically after burn injury. 13, 18, 19 The anti-infl ammatory cytokine interleukin 10 20 shows a similar pattern to that for interleukin 8. A key cytokine for inducing infl ammatory processes is TNFα, 19, 21, 22 the expression of which is characteristic and can be clearly attributed to the eff ects of burn size. Whereas the group with smaller burns had signifi cantly lower concentrations and a slight decrease over time, data from extensively burned patients showed a prolonged increase in this cytokine. The complex signalling pathway leads to several eff ects throughout the bodies of injured patients. TNFα induces production of acute phase proteins including C-reactive protein in the liver, 23 expression of interleukin 6, 15 phagocytosis in macrophages, 24 and migration of neutrophil granulocytes 25 in infected or damaged tissues. TNFα also aff ects hormone regulatory processes, especially hypothalamic thermoregulation 26 and insulin sensitivity, 27 all present in severely burned patients. 28 The importance of biomarkers examined in this study was that they showed trajectories diff erentiating survivors from non-survivors matched for burn size. These novel trajectories are of great interest because we can clearly identify molecules that are changed according to burn size, and the next step would be to propensity match patients and establish diff erences in these trajectories. The propensity matching would further eliminate the amount of fl uid resuscitation or outside factors that could cause an artifi cial iatrogenic modulation of these biomarkers. However, in this study, we showed that biomarker profi les are profoundly diff erent between the diff erent burn sizes, particularly during later timepoints, suggesting that these diff erences are not dependent on fl uid or resuscitation but endogenous synthesis and expression.
Besides the injury-driven infl ammatory response, the incidence of clinically relevant infections increased with burned area. The loss of the dermal barrier, profoundly increased metabolism, and an impaired immune system lead to a higher incidence of burn wound and nosocomial infections increasing with burn size. The eff ect of these processes on important organ functions such as renal and liver function was assessed by monitoring routine laboratory measures. Blood urea nitrogen and serum creatinine concentrations were signifi cantly increased in the larger burns group. Comparing both measures, we noted similar results as for the infl ammatory markers. Diff erences in serum creatinine disappeared after day 28 postburn, whereas blood urea nitrogen remained signifi cantly diff erent. As an explanation for these fi nd ings, we propose that metabolic breakdown and protein degradation related to burn size lead to a signifi cantly greater increase in nitrogen load in this burn group. The eff ect on the liver as a pivotal organ for metabolic homoeostasis is refl ected in concentrations of the enzyme aspartate transaminase and total bilirubin. Bilirubin is an established measure for monitoring liver function and was signifi cantly increased in the larger burn group. The initial increase during the fi rst 2 days after injury might be accounted for by the breakdown of damaged red blood cells and the transfusion of red blood cells given during the burn wound excision and grafting procedures. Aspartate transaminase is a non-liver-specifi c marker 9 that can also be found in red blood cells, heart, pancreas, kidneys, and muscle. Therefore, it might not specifi cally refl ect liver damage. The tremendous increase seen during the fi rst week in patients with burns greater than 60% TBSA might be accounted for by severe tissue damage to the skin after burn injury.
A limiting factor, which might be seen as advantageous by some in view of the endpoints used in this study, was that patients admitted to our hospital received maximum treatment irrespective of the severity of the burn injury (no do not resuscitate orders were written). This treatment regimen does not necessarily apply to all burn patients at all centres. Another limitation, yet a potential advantage, is that this study is a single-site study and did not include outcomes from other hospitals. The threshold of around 60% TBSA, therefore, might or might not apply to other burn centres. However, the use of data
Panel: Research in context
Systematic review
In Feb 3, 2011, we searched PubMed with the search terms "burn size", "pediatric", "outcomes", "mortality", "survival", "probability", and "prediction", for studies with data for outcomes and mortality after severe burn injury. Beginning with the fi rst study from 1949, publications documented the improvements in survival during the decades and provided information about the present state with regard to the extent of burn and cofactors with a last major analysis in 1998. 1 Clinical investigations reporting the results of interventional clinical trials and observational studies suggest substantial improvements in burn care. 2, 3 Novel surgical management of the burn wounds, monitoring, and pharmaceutical treatment options and regimens are thought to have improved overall survival rates during the past decade. 12, 16, 19, 23 Interpretation In this analysis, we established the crucial threshold burn size for survival in modern paediatric burn care. We showed that a burn area of 62% of total body surface area (TBSA) is a hallmark for survival. A detailed analysis of the patients stratifi ed in deciles for burn size provided an estimate of comorbidities during stay in the intensive care unit and showed an increasing incidence of multiorgan failure, infectious complications, length of hospital stay, and mortality with a major tilt point around 60% TBSA. Furthermore, a large panel of established and novel biomarkers for organ function, metabolism, and infl ammation suggests that major diff erences between the groups exist and confi rms the fi ndings of other clinical studies. Results of this study show that paediatric patients with a burn size greater than 62% TBSA are at signifi cantly increased risk of clinical complications and death.
from a single centre eliminates the diff erences that arise from multiple study sites due to homogeneous treatment protocols. In summary, the results of this study verify the clinically expected increased incidence of mortality and major changes in morbidity with increasing burn size, with a major divergence noted at around 60% TBSA burn size (panel). We show that the incidence of comorbidities increases with burn size and show a major increase over the calculated threshold. Moreover, this fi nding depends on a series of metabolic changes and clinically important organ monitoring measures, which were also shown to follow this pattern.
The relevance of this work is that we have established that, in a modern paediatric burn care setting, a burn size of roughly 60% TBSA is a crucial threshold for postburn morbidity and mortality. On the basis of these fi ndings, we recommend that paediatric patients with greater than 60% TBSA burns be immediately transferred to a specialised burn centre. Furthermore, at the burn centre, patients should be treated with increased vigilance and improved therapies, recognising the increased risk for poor outcome associated with this burn size.
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